HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$3.67
Day range
$3.60 - $3.75
Year range
$0.72 - $4.55
Market cap
206.02M USD
Avg Volume
957.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.36M | 32.97% |
Net income | -13.44M | -144.76% |
Net profit margin | — | — |
Earnings per share | -0.25 | -92.31% |
EBITDA | -11.33M | -33.90% |
Effective tax rate | 0.34% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.29M | -45.06% |
Total assets | 109.90M | -13.14% |
Total liabilities | 108.84M | 33.40% |
Total equity | 1.06M | — |
Shares outstanding | 55.68M | — |
Price to book | 183.50 | — |
Return on assets | -25.02% | — |
Return on capital | -117.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -13.44M | -144.76% |
Cash from operations | -9.93M | -36.75% |
Cash from investing | -1.78M | -125.07% |
Cash from financing | 1.38M | 127.52% |
Net change in cash | -10.37M | -98.93% |
Free cash flow | -5.13M | 42.69% |
About
Founded
2012
Headquarters
Website
Employees
36
